stooocks.com

Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.

K Health, Inc.

United States Β· Privately owned

K Health sells app-based doctor visits, prescriptions, and AI tools that help patients and health systems handle everyday medical care.

K Health is a digital health company that lets people see a doctor from their phone. You open the app, answer questions about how you feel, and a real clinician reviews your case and can prescribe medicine for common problems like a sinus infection, a urinary tract infection, or the flu. It also offers virtual primary care, where you get an ongoing relationship with a doctor rather than a one-off visit. The pitch is simple: skip the waiting room and the surprise bill, and get treated in minutes.

The clever part is the AI. K Health built a clinical tool trained on millions of real patient records that suggests likely diagnoses and next steps to doctors. It's not replacing the physician; it's doing the boring detective work so the human can decide faster. That same engine powers the consumer app, which is why a visit can cost far less than a traditional clinic trip. The company makes money in two ways: patients pay for visits and memberships, and health systems and insurers pay to license the AI tools and plug K Health into their own care. That second customer is the growth story. Hospitals and insurers are drowning in routine complaints and staffing shortages, and K Health sells them a way to handle more patients with the doctors they already have. It has struck partnerships with large health systems and insurers to power their virtual care. Competition is crowded β€” telehealth players, insurer-owned apps, and other AI triage startups are all chasing the same ground β€” but K Health's edge is that its AI was built on actual clinical data, not just a chatbot wrapper.


The company is privately held, backed by investors including Amazon, which has also used K Health's technology in its own health efforts. It was founded in 2016 and is based in New York. Like most private digital-health firms, it doesn't publish full financials, so the key question for its future is whether health systems keep buying the AI tools at scale β€” because that, not the consumer app, is where the real money is meant to come from.

Saved answer Β· last researched 16 Nov 2026